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Abstract Circadian clocks are biologic oscillators present in all photosensitive
species that produce 24-h cycles in the transcription of rate-limiting metabolic
enzymes in anticipation of the light–dark cycle. In mammals, the clock drives
energetic cycles to maintain physiologic constancy during the daily switch in
behavioral (sleep/wake) and nutritional (fasting/feeding) states. A molecular con-
nection between circadian clocks and tissue metabolism was first established with
the discovery that 24-h transcriptional rhythms are cell-autonomous and self-
sustained in cultured fibroblasts, and that clocks are present in most tissues and
comprise a robust temporal network throughout the body. A central question
remains: how do circadian transcriptional programs integrate physiologic systems
within individual cells of the intact animal and how does the ensemble of local
clocks align temporal harmonics in the organism with the environment? Our
approach to studies of metabolic regulation by the molecular clock began with
analyses of metabolic pathologies in circadian mutant animals, experiments that
first became possible with the cloning of the clock genes in the late 1990s. A
paradox in our early studies was that the effects of circadian clock disruption were
both nutrient- and time-dependent, so that, under fed conditions, animals exhibited
diabetes whereas during fasting, they decompensated and died. Application of a
broad range of tissue-specific genetic and biochemical approaches has now begun
to provide mechanistic insight into the circadian control of metabolism.
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Genetic Approaches to Dissecting Circadian Physiology
Glucose homeostasis is a dynamic process that is subjected to rhythmic variation
throughout the daily light–dark cycle. Impaired glucose regulation arises from
desynchrony in the integration of anabolic, catabolic, and incretin hormones across
the circadian cycle and leads to metabolic syndrome and diabetes mellitus, disor-
ders that are associated with over-nutrition, sedentary lifestyle, and sleep-wake
disruption common in industrialized society. Individuals with diabetes must adjust
their insulin levels differently every day and night even independently of how much
they eat; however, the molecular underpinnings of circadian glucose regulation
were previously not well understood. Genome-wide association and deep-
sequencing studies have shown that variants of the melatonin receptor 1b and
cryptochrome 2 genes correlate with glucose variation in humans, suggesting a
genetic linkage between the circadian system and glucoregulatory processes in man
(Bouatia-Naji et al. 2009; Mulder et al. 2009; Dupuis et al. 2010). Against this
backdrop, work from our laboratory using circadian clock mutant mice first
revealed an essential role for the intrinsic beta cell clock in insulin secretion, beta
cell development, and diabetes mellitus (Marcheva et al. 2010). Subsequent studies
in three other groups have corroborated our observation that local function of the
clock transcription factor in islets is crucial for normal glucose homeostasis
(Sadacca et al. 2011; Lee et al. 2013; Pulimeno et al. 2013). Importantly, work
from the Dibner laboratory has been the first to manipulate and monitor clock
function in isolated human islet cells, raising the possibility that future investigation
into circadian cell physiology will yield new understanding of beta cell failure in
man (Pulimeno et al. 2013). In recently published work, we have developed
tamoxifen-inducible Cre-LoxP technology to conditionally eliminate clock gene
function in pancreas (PMID 26542580). Remarkably, our results establish that
acute pancreatic clock ablation in the adult is sufficient to cause diabetes mellitus
in the whole animal. These new genetic studies are the first to demonstrate an
essential role for the adult circadian system in beta cell glucose regulation, although
a gap remains in our understanding of the cell and molecular bases for clock
function in the beta cell. Using conditional gene targeting and next-generation
sequencing described in the following sections, we are presently poised to dissect
the genomic, biochemical, and physiologic mechanism of the clock in beta cell
failure. Moreover, since clock transcription factors impact both islet cell growth
and stress response, we also seek to understand the role of the islet cell clock in
susceptibility to beta cell apoptosis in type 1 diabetes, in islet regenerative capacity,
and in islet cell survival in insulin resistant obesity.
Our analysis of the beta cell clock also opens broader insight into the role of
transcription factor deregulation in beta cell failure and the unifying and distinct
molecular events between tissues that culminate in diabetes mellitus. In this regard,
positional cloning of genes causing Maturity Onset Diabetes of the Young (MODY)
in humans has revealed that the hepatic nuclear factor (HNF) network of forkhead
transcription factors plays a critical role in beta cell development and function,
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although knowledge of the cell-context specific determinants of HNF action in liver
and pancreas remains incomplete. By analogy, an important goal in understanding
how beta cell transcription defects related to the clock pathway give rise to diabetes
will be to elucidate differences in the clock-controlled enhancer network in liver
and pancreas and to compare the cistromes and transcriptomes for these factors in
each tissue. Interestingly, there is coincidence of CLOCK/BMAL1 binding sites in
liver at loci marked by monomethylated H3K4 in pancreas, although it is not known
whether the enhancer state (poised, H3K4me1 vs active, H3K4me1 with H3K27Ac)
in pancreas varies over the 24-h cycle. In the long term it will be necessary to
evaluate the cistromes and localization of clock factors with established transcrip-
tion factors involved in beta cell function over the full circadian cycle in both liver
and pancreas. Such studies will further elucidate the mechanism by which the clock
controls gene transcription networks involved in insulin release, namely by deter-
mining the extent to which CLOCK/BMAL1 directly binds to promoters and/or
enhancers or regulates epigenetic chromatin modifiers that determine accessibility
to transcription factors and RNA polymerase genome-wide. Overall, studies of the
beta cell molecular clock will elucidate how glucose homeostasis is coupled to the
light/dark cycle and the transcriptional determinants of circadian physiology.
Clock-NAD+-Sirtuin Pathway in Bioenergetics
Amajor step in understanding how the clock-NAD+ cycle impacts physiology came
from the observations that circadian mutant mice become hypoglycemic and die
when subject to a prolonged fast (PMID 24051248, unpublished data) and also
exhibit muscle and heart failure (PMID 20956306, 21452915), all hallmarks of
mitochondrial disease, which prompted us to dissect the mechanisms of clock
regulation of mitochondrial function. We began our investigation into the effect
of NAD+ deficiency on mitochondrial function in circadian mutant animals using a
multi-faceted approach, including unbiased proteomics, which led to the identifi-
cation of abnormal acetylation of enzymes involved in lipid oxidation, amino acid
catabolism, tricarboxylic acid (TCA) cycle, electron transport chain (ETC), and
superoxide dismutase pathways. Importantly, loss-of-function mutations in several
of these oxidative enzymes have also been identified in the human metabolic
myopathy syndrome and in both glioblastoma and renal cell carcinoma, indicating
a broader effect of the clock-NAD+ pathway on mitochondrial metabolism in both
normal and transformed cells. Using tissue- and cell-based bioenergetics assays, we
discovered that abrogation of the clock impairs electron transfer from lipid to the
TCA cycle, in addition to increased mitochondrial production of superoxide free
radical, increasing sensitivity to genotoxic stress. Our work also showed that cells
exhibit an autonomous rhythm of oxygen consumption, glucose oxidation, and
mitochondrial lipid catabolism. Importantly, the oxygen consumption cycle in
muscle is directly linked to metabolism of NAD+ and activity of the mitochondrial
NAD+-dependent deacetylase SIRT3 (Peek et al. 2013).
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Although the aforementioned work has pinpointed specific defects in clock
control of mitochondrial function, several unanswered questions remain in
dissecting the effect of clock-NAD+ rhythms on physiology and cell biology.
First, it is not yet known how NAD+ deficiency locally within skeletal muscle
contributes to respiration or exercise tolerance in circadian mutant mice or in
animals subjected to environmental circadian disruption. Though skeletal muscle
ablation of the clock has been achieved in our group and others, the biochemical
pathways through which clock abrogation impairs oxidative capacity remain
largely unknown (Dyar et al. 2014).
Second, we still do not know whether clock abrogation and NAD+ deficiency in
liver or skeletal muscle impacts overall energy balance and alters the capacity to
utilize carbohydrate and lipid as a fuel source. New pharmacologic (Wang
et al. 2014) and genetic means to raise NAD+ both globally in the whole animal
and selectively within either liver or skeletal muscle are now available and will be
powerful tools in evaluating the potential to boost NAD+ as a therapeutic strategy in
myopathy and liver defects of circadian mutant animals. Finally, in addition to its
function as a cofactor for the class III histone deacetylases, NAD+ is a cofactor for
the poly-ADP-ribosylases, critical factors in DNA repair and stress response,
though the possible interaction between rhythmic regulation of NAD+ and PARP
activity is not known. Lastly, NAD+ functions as an electron transport molecule
and, as such, it is a direct marker of cellular redox state and the balance between
glycolytic and oxidative metabolism. Whether NAD+ might participate in the
bidirectional communication between metabolism and the clock system remains
an area of intensive investigation. In summary, discovery of the clock as an
upstream regulator of NAD+ provides a wealth of opportunity to dissect the
interrelationship between circadian rhythms, physiology, and epigenetics.
Reciprocal Control of the Clock by Nutrient
Circadian clocks are biologic oscillators that produce 24-h cycles in the transcrip-
tion of rate-limiting metabolic enzymes in anticipation of the solar cycle. The
molecular clock is programmed by a transcription-translation feedback loop that
is comprised of activators (CLOCK/BMAL1) that induce the expression of their
own repressors (CRYs/PERs) in a cycle that repeats itself every 24 h. The
REV-ERB and ROR proteins form an ancillary loop that modulates Bmal1 tran-
scription. In animals, clocks are organized hierarchically, with brain pacemaker
cells synchronizing peripheral tissue clocks, leading to a classical view of the
central clock as the main driver of metabolism. However, circadian oscillations
within both brain and peripheral tissues have recently been shown to be sensitive to
timing of nutrient availability and can become uncoupled from the light–dark cycle,
as demonstrated by experimentally restricting food access to the light cycle when
mice are normally resting (Damiola et al. 2000; Stokkan et al. 2001). Further,
simply substituting regular with high fat chow in mice fed ad libitum lengthens
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periodicity of locomotor activity and alters peripheral metabolic rhythms, providing
further evidence for a bidirectional relationship between clock function and metab-
olism (Kohsaka et al. 2007). Our discovery that diet-induced obesity reprograms
both the cellular molecular clock and behavior revealed for the first time that a
controlled change in nutritional environment leads to altered circadian rhythms.
This idea, that circadian and metabolic systems reciprocally interact and that
perturbation of the metabolic environment alters the homeostatic relationship
between these systems, has been widely confirmed but still remains poorly under-
stood at the mechanistic level. Human analyses, including genome-wide associa-
tion studies, population based case–control investigation, and clinical research,
have cumulatively indicated a strong interrelationship between circadian disrup-
tion, obesity, diabetes mellitus, and metabolic syndrome. Moreover, certain inflam-
matory and cardiovascular events, including thrombosis and nocturnal asthma,
exhibit pronounced circadian variation. Surprisingly, dietary macronutrient directly
impacts behavioral and molecular clock function, and circadian disruption itself
exacerbates the progression of diet-induced obesity, exerting distinct effects within
local metabolic organs. Moreover, limiting high-fat food to the incorrect circadian
phase accelerates weight gain, whereas limiting high-fat feeding to the correct
phase ameliorates hepatic steatosis, a hallmark of metabolic syndrome (Maury
et al. 2010). While we previously demonstrated that diet-induced obesity repro-
grams the cellular molecular clock and circadian behavior, we have more recently
sought to identify the macronutrient disruptor of circadian behavior by providing
mice an isocaloric diet high in either saturated or unsaturated fats (SFD and UFD).
Our goal is to identify the mechanism by which a macronutrient directly alters
behavior and neuronal circadian pacemaker function. We propose that nutrient
signaling plays a central role in inter-organ circadian communication and that
circadian disruption induced by high saturated fat contributes to the rate of pro-
gression of metabolic syndrome.
Summary and Future Directions
A major window to understanding how the clock is coupled to metabolism was
opened with discovery of metabolic syndrome pathologies in multi-tissue circadian
mutant mice, including susceptibility to diet-induced obesity, mis-timed feeding
rhythms, hypoinsulinemia, and energetic collapse upon fasting. Using Cre-LoxP
conditional transgenesis and dynamic endocrine testing, we have pinpointed the
tissue-specific role of the clock in energy and glucose homeostasis, with our most
detailed understanding of this process in liver, muscle, and endocrine pancreas. In
the post-prandial condition, the beta cell clock is essential for nutrient and adenyl
cyclase-induced insulin exocytosis. In contrast, the hepatocyte and myocyte clocks
are required for oxidative metabolism. Circadian mutant mice die upon prolonged
fasting due to mitochondrial failure, a defect that we have tied to the bioavailability
of NAD+, a cofactor of the class III histone deacetylases and poly-ADP ribosylase
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enzymes involved in adjusting metabolic and gene regulation in response to
environmental change, including glucose deprivation, oxidative damage, and cell
stress. Indeed, we have found that liver and myoblasts exhibit an autonomous
rhythm of oxygen consumption, glucose oxidation, and mitochondrial lipid catab-
olism that is directly linked to an autonomous rhythm of NAD+ metabolism and,
consequently, to cyclic activity of the mitochondrial NAD+-dependent deacetylase
SIRT3. NAD+ supplementation using the pro-drug NMN improves respiration in
live animals, indicating that circadian control of NAD+ metabolism plays a key role
in cellular and organismal respiration. A future challenge will be to determine the
cell and molecular basis for the interplay between nutritional and circadian pro-
cesses important in metabolic health and disease states.
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